And that’s undoubtedly been part of Trump’s point with his recent flurry of absurdities. He’s already testing how far he can ...

In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...

In a report released yesterday, Gordon Johnson from GLJ Research maintained a Buy rating on SolarEdge Technologies (SEDG – Research Report), ...